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SUMMARY – Burkitt lymphoma, a type of non-Hodgkin B-cell lymphoma, is the fastest grow-
ing human cancer, presenting pathologically with a ‘starry sky’ pattern. It is most often found in the 
abdomen and the jaw, however, localization in the abdomen other than the ileocecal area is very rare 
and described only in a handful of cases. Standard treatment consists of initial tumor cytoreduction 
followed by intense chemotherapy. Most of the relapses occur within one year of the diagnosis, while 
the 5-year survival is around 80%. We present two cases which are specific for unusual location of 
Burkitt lymphoma in the colon and stomach, in immunocompetent patients with negative Epstein-
Barr virus tests. Also, one of the patients presented is one of the oldest ever reported with abdominal 
Burkitt lymphoma, while the other patient is an example of diagnostic difficulties in distinguishing 
Burkitt lymphoma from similar lymphomas. Due to the rapidly growing tumors and urgent need for 
cytoreductive surgery, it is crucial to consider the diagnosis of Burkitt lymphoma even in atypical lo-
calizations or absence of the common risk factors associated with Burkitt lymphoma.
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Introduction
Burkitt lymphoma (BL) is a type of non-Hodgkin 
B-cell lymphoma, found endemically in equatorial 
 Africa and New Guinea in children infected with ma-
laria and Epstein Barr virus (EBV), in immunocom-
promised patients, or as a sporadic form in Western 
countries1. BL consists of uniform medium-sized B-
lymphocytes with basophilic cytoplasm, numerous 
 mitoses, and apoptosis. Macrophages are scattered 
among tumor cells, giving BL a distinctive histologic 
appearance called “starry sky pattern”2.
Tumor cells express membrane immunoglobulin 
(Ig) M, Ig light chain, B-cellular antigen, B-cell 
 lymphoma (BCL) protein 6, cluster of differentiation 
(CD) 10, 19, 20 and 22, while expressing negative re-
sults for CD 5, 23, and BCL 2. The most common 
cytogenetic change is t(8;14)(q24;q32), t(q11;q24) or 
t(8,22)(q24;q11) translocation. The proliferation index 
(Ki67) of BL is very high, usually over 95%, so it is 
not surprising that BL is the fastest growing human 
cancer3-5.
In adults, BL is most often found in the abdomen, 
followed by the jaw, while central nervous system dis-
ease is reported in up to 40% of patients. Localization 
other than the ileocecal area is very rare. BL can pres-
ent as abdominal or jaw pain, melena, nausea, or even 
acute abdomen6,7, although the symptoms depend on 
the primary localization and spread of the tumor.
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Standard treatment consists of initial tumor cyto-
reduction followed by several cycles of intense chemo-
therapy based on high doses of cyclophosphamide, 
methotrexate, rituximab, and intrathecal application of 
cytostatics along with other necessary supportive med-
ications8,9.
Relapses mostly occur within one year of the diag-
nosis, while the 5-year survival is around 80%. Around 
10%-15% of patients die due to complications during 
treatment, while 5%-10% die from BL. Prognosis de-
pends on patient age and spread of the disease. Adult 
patients with localized disease have a better prognosis 
than those with metastatic disease. On the other hand, 
children have a much better prognosis than adults, 
even in case of low stage disease10.
In the cases presented, appropriate informed con-
sent was obtained, and we ensured everything to pro-
tect the patients’ identity, respecting the highest ethical 
standards.
Case 1
A 73-year-old male Caucasian complained of he-
matochezia and symptoms of severe anemia. He had 
been operated for laryngeal cancer seven years before, 
without other oncologic treatment, and had a perfo-
rated gastric ulcer 19 years before; his previous medical 
history also included diabetes mellitus.
Esophagogastroduodenoscopy (EGDS) was per-
formed following the work-up in the Emergency De-
partment, but no recent signs of bleeding were found. 
Fig. 1. Colonoscopy view of the tumor in the hepatic 
flexure.
Fig. 2. Colonoscopy view of the tumor in the hepatic 
flexure.
Fig. 3. Histology of Burkitt lymphoma found in the colon 
(HE, magnification X200). Histopathologic appearance 
of starry sky pattern: solid sheets of middle-sized atypical 
lymphocytes, with scattered macrophages.
Colonoscopy followed, displaying a tumorous mass in 
the area of hepatic flexure of the colon (Figs. 1 and 2). 
The histopathologic diagnosis was BL (Fig. 3). Immu-
nohistochemically, tumor cells were negative for 
panCK, chromogranin, synaptophysin and CD5, and 
positive for LCA and CD20, with Ki67 over 95%.
For staging purposes, multi-slice computed to-
mography (MSCT) of the abdomen was performed, 
showing a sizeable neoplastic process of hepatic flex-
ure with regional lymphadenopathy. No other radio-
logical abnormality was described. The case was pre-
sented to a multidisciplinary team for colorectal can-
cer, and a surgical procedure of right-sided hemi-
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colectomy with latero-lateral (LL) anastomosis was 
suggested and later performed.
Adjuvant therapy consisted of EPOCH protocol 
along with palonosetron and other necessary support-
ive treatment.
Case 2
A 39-year-old male Caucasian started diagnostic 
procedure due to pain in the upper abdomen without 
any other symptoms. EGDS was performed to show a 
stomach mass and biopsy was done. There were seven 
biopsy specimens of 3 mm in size; histopathologically, 
these were gastric mucosal fragments infiltrated with 
dense atypical lymphocytes, with no starry sky mor-
phology. On immunohistochemical analysis, tumor 
cells were CD20+, CD10+, Bcl6+, cyclinD1-, and 
nearly 90% Ki67 positive. The histopathologic diagno-
sis was non-Hodgkin lymphoma, diffuse large B-cell 
lymphoma, not otherwise specified (DLBCL NOS), 
with the origin most likely from the germinative cen-
ter. No further cytogenetic analysis was performed, 
and an R-CHOP chemotherapy protocol was applied.
Two months later, the patient was hospitalized as 
an emergency due to melena. EGDS was performed 
again to show an exulcerated tumor mass (Figs. 4 and 
5). Thorax CT scan confirmed disease progression 
with enlarged regional lymph nodes and intratumoral 
necrosis despite therapy. On multidisciplinary team 
consultation, operative treatment was suggested. The 
Fig. 7. Ki67 positivity of 100% tumor cells 
(magnification X200).
Fig. 4. Tumorous formation in the stomach as displayed 
on EGDS.
Fig. 5. Tumorous formation in the stomach as displayed 
on EGDS.
Fig. 6. Histology of Burkitt lymphoma found in the 
stomach (HE, magnification X200): starry sky pattern.
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preoperative process was complicated with secondary 
obstructive cholangitis due to tumor compression.
Finally, gastrectomy with regional lymphadenec-
tomy, omentectomy and cholecystectomy was per-
formed. On gross pathologic examination, the stom-
ach, the surrounding fat tissue with lymph nodes and 
the gallbladder wall were infiltrated by tumor tissue. 
Morphologically, the tumor consisted of monomor-
phic medium-sized atypical lymphatic cells with scant 
basophilic cytoplasm, round nuclei with multiple nu-
cleoli, with numerous mitoses and apoptotic cells and 
with starry sky appearance (Fig. 6). Immunohisto-
chemically, tumor cells were positive for CD20, CD10 
and Bcl6, and almost negative for Bcl2. Ki67 was 
100% (Fig. 7).
Since the morphology and proliferation rate were 
not the same as on the small endoscopic biopsy, and 
there was rapid tumor progression despite the therapy 
administered, the diagnosis was changed to BL.
After the patient had stabilized, a prephase with 
GMALL protocol was suggested. Unfortunately, the 
patient died in another hospital before starting the 
treatment.
Discussion
Adult sporadic BL is commonly a disease of young 
male adults in their twenties and thirties. Both of our 
patients were male, but the first patient was much old-
er than expected for BL. Both patients presented with 
sporadic BL, not associated with immunocompro-
mised status (HIV negative) and EBV infection, which 
was also unexpected. Tumor localization in the hepatic 
flexure (case 1) and stomach (case 2) is not a typical 
manifestation of the disease either, described only in a 
handful of cases11,12. Hence, both of our cases serve to 
emphasize the fact that old age, along with gastroin-
testinal localization, does not exclude the possibility of 
BL and should be a viable differential diagnosis for 
high-grade non-Hodgkin lymphoma even in patients 
older than 70 years.
The main challenge in diagnosing BL is distinction 
between BL and diffuse large B-cell lymphoma, which 
is difficult. Distinguishing between these two lympho-
mas, however, is critical, especially in adults, as the two 
diseases are treated differently3,13,14. Our second case 
report serves to stress the problem with distinction be-
tween the two types of lymphomas. When atypical age 
or localization might point to diffuse large B-cell lym-
phoma, we still need to be wary of the possibility of 
BL, and dubious cases should undergo genetic testing 
and additional analysis.
Early diagnosis of BL is also essential to prevent 
life-threatening complications that occur due to high 
tumor burden and fast increase in size. The second case 
is a blatant example of the former, with two life-
threatening gastrointestinal complications occurring 
in quick succession, gastrointestinal bleeding and sec-
ondary cholangitis after lymph node induced bile duct 
compression.
With the advancement of medicine and longer 
survival, it is necessary to consider that BL will appear 
more often in atypical localization or age group, even 
without typical risk factors associated with the disease. 
These case reports emphasize the importance of clini-
copathologic correlation in the diagnosis of high-
grade lymphomas in everyday practice.
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Sažetak
BURKITTOV LIMFOM U PROBAVNOM TRAKTU: PRIKAZ 2 SLUČAJA
A. Čubranić, M. Golčić, D. Fučkar-Čupić, B. Brozović, D. Gajski i I. Brumini
Burkittov limfom spada u non-Hodgkin B-stanične limfome te je najbrže rastući tumor u ljudi, a patološki se prezentira 
uzorkom ‘zvjezdanog neba’. Najčešće je lokaliziran u trbuhu i u čeljusti, međutim, lokalizacija u trbuhu izvan ileocekalnog 
područja je izrazito rijetka i opisana samo u nekoliko slučajeva. Uobičajeno liječenje se sastoji od inicijalne citoredukcije 
 tumora nakon čega slijedi intenzivna kemoterapija. Većina recidiva javi se unutar jedne godine od dijagnoze, dok je petogo-
dišnje preživljenje oko 80%. U članku prikazujemo dva slučaja koja su specifična zbog rijetke lokalizacije Burkittova limfoma 
u debelom crijevu i želudcu, u imunokompetentnih bolesnika s negativnim testom na Epstein-Barrov virus. Također, jedan 
od opisanih bolesnika je jedan od najstarijih slučajeva abdominalnog Burkittova limfoma opisanih u literaturi, dok slučaj 
drugog bolesnika naglašava izazove u dijagnostici Burkittova limfoma, osobito u bolesnika kod kojih se isti ne očekuje. S 
obzirom na brz rast tumora i hitnu potrebu citoreduktivne operacije važno je uzeti u obzir dijagnozu Burkittova limfoma čak 
i u bolesnika s netipičnom lokalizacijom tumora i bez uobičajnih rizičnih čimbenika povezanih s Burkittovim limfomom.
Ključne riječi: Burkittov limfom; Prikazi slučaja; Kolon; Citoredukcijski kirurški postupci
